F.Z.: Participation in a scientific advisory board or lecturing activity for Novartis, Roche, Celgene, AC-264613 Janssen, Novartis Pharma, Janssen Pharmaceutica, Sandoz International, F. therapy option. Alternatively, treatment can be initiated with a high-efficacy DMT already at the time of diagnosis, for example, with alemtuzumab, cladribine, natalizumab, ocrelizumab, ofatumumab, or S1P modulators (fingolimod, ozanimod, ponesimod). Data […]